Product Information
LABETALOL HCL 300 MG TABLET is a generic product labeled by Biocon Pharma Inc., priced at $0.2086 per EA under NDC 70377006213. Its NADAC has been published 246 times since Oct 13, 2021.
The High Outlier badge above means this manufacturer's average price in the Labetalol Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Biocon Pharma Inc.NDC
70377006213
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LABETALOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209603On Market Since
5/27/2021
Pharmacological Classes
Price Statistics
The NADAC for LABETALOL HCL 300 MG TABLET has been published 246 times since Oct 13, 2021, and over the history we have for it it has declined 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2086 per EA |
|---|---|
| All-time high | $0.2383 (Aug 10, 2022) |
| All-time low | $0.1776 (Nov 20, 2024) |
| 52-week high | $0.2117 |
| 52-week low | $0.1998 |
| Median price | $0.2093 |
| Average price | $0.2102 |
| Largest weekly change | -16.9% (Jul 17, 2024) |
| Weeks tracked | 246 |
| Tracking since | Oct 13, 2021 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LABETALOL HCL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 300 MG TABLET, manufactured by Biocon Pharma Inc., is $0.2086 per EA (NDC 70377006213), effective Jun 24, 2026.
How has the price of LABETALOL HCL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for LABETALOL HCL 300 MG TABLET has declined 12.1%. It has been tracked across 246 weekly CMS publications since Oct 13, 2021.
What are the highest and lowest recorded NADAC prices for LABETALOL HCL 300 MG TABLET?
Since Oct 13, 2021, the NADAC for LABETALOL HCL 300 MG TABLET has ranged from a low of $0.1776 (Nov 20, 2024) to a high of $0.2383 (Aug 10, 2022), with a median of $0.2093 per EA.
Are there cheaper alternatives to LABETALOL HCL 300 MG TABLET?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LABETALOL HCL 300 MG TABLET, is $0.2041 per EA — about 2% below LABETALOL HCL 300 MG TABLET.
Who manufactures LABETALOL HCL 300 MG TABLET?
LABETALOL HCL 300 MG TABLET (NDC 70377006213) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification